These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 11710796

  • 1. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD.
    Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
    [Abstract] [Full Text] [Related]

  • 2. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.
    Freeman R, Landsberg L, Young J.
    Neurology; 1999 Dec 10; 53(9):2151-7. PubMed ID: 10599797
    [Abstract] [Full Text] [Related]

  • 3. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
    Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ, NOH301 Investigators.
    Neurology; 2014 Jul 22; 83(4):328-35. PubMed ID: 24944260
    [Abstract] [Full Text] [Related]

  • 4. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
    Iida N, Koshikawa S, Akizawa T, Tsubakihara Y, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M.
    Am J Nephrol; 2002 Jul 22; 22(4):338-46. PubMed ID: 12169865
    [Abstract] [Full Text] [Related]

  • 5. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R.
    Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750
    [Abstract] [Full Text] [Related]

  • 6. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS, Holmes C, Kaufmann H, Freeman R.
    Clin Auton Res; 2004 Dec 12; 14(6):363-8. PubMed ID: 15666063
    [Abstract] [Full Text] [Related]

  • 7. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
    Kaufmann H.
    Clin Auton Res; 2008 Mar 12; 18 Suppl 1():19-24. PubMed ID: 18368303
    [Abstract] [Full Text] [Related]

  • 8. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance.
    Tanaka H, Yamaguchi H, Mino M.
    Clin Auton Res; 1996 Aug 12; 6(4):189-93. PubMed ID: 8902314
    [Abstract] [Full Text] [Related]

  • 9. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
    Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, de Freitas AF.
    J Auton Nerv Syst; 1997 Jan 12; 62(1-2):63-71. PubMed ID: 9021651
    [Abstract] [Full Text] [Related]

  • 10. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G, Holmes C, Sullivan P, Goldstein DS.
    Clin Auton Res; 2019 Feb 12; 29(1):113-117. PubMed ID: 30229336
    [Abstract] [Full Text] [Related]

  • 11. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
    Mathias CJ.
    Clin Auton Res; 2008 Mar 12; 18 Suppl 1():25-9. PubMed ID: 18368304
    [Abstract] [Full Text] [Related]

  • 12. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
    Birkmayer W, Birkmayer G, Lechner H, Riederer P.
    J Neural Transm; 1983 Mar 12; 58(3-4):305-13. PubMed ID: 6420517
    [Abstract] [Full Text] [Related]

  • 13. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Matsumoto M, Yoneda S.
    Eur Neurol; 1985 Mar 12; 24(5):330-4. PubMed ID: 3932074
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure.
    Kaufmann H, Oribe E, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1991 Mar 12; 3(2):143-8. PubMed ID: 1910486
    [Abstract] [Full Text] [Related]

  • 15. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy.
    Gibbons CH, Vernino SA, Kaufmann H, Freeman R.
    Neurology; 2005 Oct 11; 65(7):1104-6. PubMed ID: 16217067
    [Abstract] [Full Text] [Related]

  • 16. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.
    Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, Droxidopa 302 Investigators.
    Hypertension; 2015 Jan 11; 65(1):101-7. PubMed ID: 25350981
    [Abstract] [Full Text] [Related]

  • 17. Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
    Akizawa T, Koshikawa S, Iida N, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M, Tubakihara Y.
    Nephron; 2002 Apr 11; 90(4):384-90. PubMed ID: 11961396
    [Abstract] [Full Text] [Related]

  • 18. L-threo-3,4-dihydroxyphenylserine enhances the orthostatic responses of plasma renin activity and angiotensin II in multiple system atrophy.
    Yoshizawa T, Fujita T, Mizusawa H, Shoji S.
    J Neurol; 1999 Mar 11; 246(3):193-7. PubMed ID: 10323317
    [Abstract] [Full Text] [Related]

  • 19. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.
    Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H.
    Neurology; 2018 Oct 16; 91(16):e1539-e1544. PubMed ID: 30232253
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
    Isaacson S, Vernino S, Ziemann A, Rowse GJ, Kalu U, White WB.
    J Am Soc Hypertens; 2016 Oct 16; 10(10):755-762. PubMed ID: 27614923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.